|
|
|
| Transjugular portosystemic shunt for early-onset refractory ascites after liver transplantation |
| Giuseppe Bianco, Marco Maria Pascale ∗, Francesco Frongillo, Erida Nure, Salvatore Agnes, Gabriele Spoletini |
General Surgery and Liver Transplant Unit, Fondazione IRCCS - Policlinico Universitario “A. Gemelli”, Rome 00168, Italy
∗ Corresponding author.
E-mail address: pascale.marco.maria@gmail.com (M.M. Pascale). |
|
|
|
|
Abstract Liver transplantation (LT) is the most effective treatment for end-stage liver disease and complications of portal hypertension (PHT). However, PHT can relapse as a consequence of viral, alcoholic or metabolic chronic liver disease (CLD) recurrence, rejection, vascular abnormalities, small-for-size syndrome and technical complications (e.g., portal or hepatic veins stenosis and/or thrombosis) [1] .
|
|
|
|
|
|
|
|
|
2021, Vol. 20 
